Genetic interactions in the β-adrenoceptor/G-protein signal transduction pathway and survival after coronary artery bypass grafting: a pilot study.

BACKGROUND In heart failure, β-adrenergic receptor (βAR) stimulation desensitizes the receptor, uncouples the downstream Gαs protein, and diminishes signal transduction. We tested the hypotheses that haplotype-tagging single-nucleotide polymorphisms (htSNPs) within the Gαs gene (GNAS) (i) are functionally active and alter Gαs expression, (ii) influence survival after coronary artery bypass grafting (CABG), and (iii) interact with βAR SNPs. METHODS Amplification of GNAS intron 1 was followed by cloning, reporter assays, electrophoretic mobility shift assays, and western blots. In a pilot study, 185 patients on βAR blockade undergoing CABG were studied prospectively. The primary endpoint was cardiac-related mortality at 1 yr. RESULTS Two htSNPs defined three common haplotypes with altered reporter activity, allele-specific transcription factor binding, and Gαs protein expression (highest in *3 carriers followed by *2 and *1 haplotypes, P=0.013). After CABG, mortality was GNAS diplotype-dependent: *3/*3: 0%; *3/*2: 2.4%; *3/*1: 2.9%; *2/*2: 4.5%; *2/*1: 9.1%; and *1/*1: 20.0% (P=0.004). While β(1)AR SNPs were not associated with mortality, β(2)AR Arg16 allele carriers were at higher risk than Gly16 allele carriers (P=0.008). Gene-gene interaction using gene-related risk alleles demonstrated the number of risk alleles to be independently associated with death (hazard ratio 2.3; 95% confidence interval: 1.5-3.5; P=0.0003). Carriers of the no-risk allele had higher maximum isoproterenol-stimulated adenylyl cyclase activities than risk allele carriers (P=0.003). CONCLUSIONS Interactions in the βAR/Gαs pathway may be associated with altered mortality after CABG. This could reconcile previously inconclusive data regarding the effects of βAR SNPs on cardiovascular prognosis.

[1]  E. Peterson,et al.  Preoperative beta-blocker use and mortality and morbidity following CABG surgery in North America. , 2002, JAMA.

[2]  S. Vatner,et al.  Beta-adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic G(salpha) mouse. , 1999, The Journal of clinical investigation.

[3]  R. Kim,et al.  The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization. , 2001, The New England journal of medicine.

[4]  S. Vatner,et al.  β-Adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic Gsα mouse , 1999 .

[5]  I. Zineh,et al.  Relation of beta(2)-adrenoceptor haplotype to risk of death and heart transplantation in patients with heart failure. , 2007, The American journal of cardiology.

[6]  S. Humphries,et al.  Role of β adrenergic receptor polymorphisms in heart failure: Systematic review and meta‐analysis , 2008, European journal of heart failure.

[7]  Julie A. Johnson,et al.  Pharmacogenetics of beta-blockers. , 2007, Pharmacotherapy.

[8]  Martin J. Lohse,et al.  β2-Adrenergic Receptor Redistribution in Heart Failure Changes cAMP Compartmentation , 2010, Science.

[9]  M. McCaul,et al.  Differential expression of guanosine triphosphate binding proteins in men at high and low risk for the future development of alcoholism. , 1994, The Journal of clinical investigation.

[10]  O. Brodde β1‐ and β2‐Adrenoceptor polymorphisms and cardiovascular diseases , 2008 .

[11]  S. Vatner,et al.  Adverse Effects of Chronic Endogenous Sympathetic Drive Induced by Cardiac Gsα Overexpression , 1996 .

[12]  W. Kraus,et al.  Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprolol. , 2008, Journal of the American College of Cardiology.

[13]  E. Peterson,et al.  Preoperative beta-blocker use and mortality and morbidity following CABG surgery in North America. , 2002, JAMA.

[14]  R. Schmieder,et al.  A novel-1364A/C aquaporin 5 gene promoter polymorphism influences the responses to salt loading of the renin-angiotensin-aldosterone system and of blood pressure in young healthy men , 2008, Basic Research in Cardiology.

[15]  U. Frey,et al.  PCR-amplification of GC-rich regions: 'slowdown PCR' , 2008, Nature Protocols.

[16]  S. Vatner,et al.  Adverse effects of chronic endogenous sympathetic drive induced by cardiac GS alpha overexpression. , 1996, Circulation research.

[17]  K. Santos,et al.  Impact of beta1-adrenergic receptor polymorphisms on susceptibility to heart failure, arrhythmogenesis, prognosis, and response to beta-blocker therapy. , 2008, The American journal of cardiology.

[18]  Y. Ishikawa,et al.  Overexpression of Gs alpha protein in the hearts of transgenic mice. , 1995, The Journal of clinical investigation.

[19]  S. Vatner,et al.  Cardiomyopathy induced by cardiac Gs alpha overexpression. , 1997, The American journal of physiology.

[20]  Julie A. Johnson,et al.  Pharmacogenetics of β‐Blockers , 2007 .

[21]  M. Ergun,et al.  Association of β‐1 and β‐2 adrenergic receptor gene polymorphisms with myocardial infarction , 2009, Journal of clinical laboratory analysis.

[22]  U. Frey,et al.  A novel functional haplotype in the human GNAS gene alters Galphas expression, responsiveness to beta-adrenoceptor stimulation, and peri-operative cardiac performance. , 2009, European heart journal.

[23]  J. Blouin,et al.  &bgr;2-Adrenoceptor Genotype Affects Vasopressor Requirements during Spinal Anesthesia for Cesarean Delivery , 2006 .

[24]  J. Seidman,et al.  Natriuretic Peptide System Gene Variants Are Associated with Ventricular Dysfunction after Coronary Artery Bypass Grafting , 2009, Anesthesiology.

[25]  P. McCullagh,et al.  Some aspects of analysis of covariance. , 1982, Biometrics.

[26]  C. Londos,et al.  A highly sensitive adenylate cyclase assay. , 1974, Analytical biochemistry.

[27]  G. Heusch,et al.  β1‐ and β2‐Adrenoceptor polymorphisms and cardiovascular diseases , 2009 .

[28]  P. Ghahramani,et al.  Influence of genetic polymorphisms in the β2-adrenoceptor on desensitization in human lung mast cells , 2000 .

[29]  K. Jöckel,et al.  A novel promoter polymorphism in the human gene GNAS affects binding of transcription factor upstream stimulatory factor 1, G&agr;s protein expression and body weight regulation , 2008, Pharmacogenetics and genomics.

[30]  J. Spertus,et al.  Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome. , 2005, JAMA.

[31]  T. Lumley,et al.  &bgr;2-Adrenergic Receptor Polymorphisms and Risk of Incident Cardiovascular Events in the Elderly , 2003, Circulation.

[32]  I. Zineh,et al.  Relation of β2-Adrenoceptor Haplotype to Risk of Death and Heart Transplantation in Patients With Heart Failure , 2007 .

[33]  J. Spertus,et al.  β2-Adrenergic Receptor Genotype and Survival AmongPatients Receiving β-Blocker Therapy After an Acute Coronary Syndrome , 2005 .

[34]  O. Brodde Beta 1- and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. , 1991, Pharmacological reviews.

[35]  H. Hense,et al.  Characterization of the GNAQ promoter and association of increased Gq expression with cardiac hypertrophy in humans. , 2008, European heart journal.

[36]  Paul Bentley,et al.  Down but not out: candidate gene-based studies still have value in a world dominated by whole genome approaches. , 2010, Circulation research.

[37]  Jaekyu Shin Pharm.D. and Pharmacogenetics of β-Blockers , 2012 .

[38]  H. Völzke,et al.  Angiotensin I-converting enzyme insertion/deletion polymorphism and cardiac mortality and morbidity after coronary artery bypass graft surgery. , 2002, Chest.

[39]  S. Vatner,et al.  Overexpression of myocardial Gsalpha prevents full expression of catecholamine desensitization despite increased beta-adrenergic receptor kinase. , 1998, The Journal of clinical investigation.

[40]  M. Packer,et al.  Neurohormonal interactions and adaptations in congestive heart failure. , 1988, Circulation.

[41]  J. Blouin,et al.  beta2-adrenoceptor genotype affects vasopressor requirements during spinal anesthesia for cesarean delivery. , 2006, Anesthesiology.

[42]  P. Amouyel,et al.  The impact of beta‐adrenoreceptor gene polymorphisms on survival in patients with congestive heart failure * , 2005, European journal of heart failure.